Oral Immunotherapy Combined with Omalizumab for High-risk Cow's Milk Allergy: a Randomized Controlled Trial

Overview

Journal Sci Rep

Specialty Science

Date 2017 Dec 14

PMID 29234055

Citations 21

Authors

Masaya Takahashi

Kazuhiko Soejima

Shoichiro Taniuchi

Yasuko Hatano

Sohsaku Yamanouchi

Hideki Ishikawa

Makoto Irahara

Youhei Sasaki

Hiroshi Kido

Kazunari Kaneko

Affiliations

Soon will be listed here.

Abstract

We evaluated the efficacy and safety of oral immunotherapy (OIT) combined with 24 weeks of omalizumab (OMB) at inducing desensitization in children with cow's milk allergy (CM) compared with an untreated group. The present study was a prospective randomized controlled trial. Sixteen patients (age, 6-14 years) with high IgE levels to CM were enrolled in the present study. Patients were randomized 1:1 to receive OMB-OIT group or untreated group. The primary outcome was the induction of desensitization at 8 weeks after OMB was discontinued in OMB-OIT treated group and at 32 weeks after study entry. None of the 6 children in the untreated group developed desensitization to CM while all of the 10 children in the OIT-OMB treated group achieved desensitization (P < 0.001). A significantly decreased wheal diameter in response to a skin prick test using CM was found in the OMB-OIT treated group (P < 0.05). These data suggest that OIT combined with OMB using microwave heated CM may help to induce desensitization for children with high-risk CM allergy. This prospective randomized controlled trial was intended for 50 participants but was prematurely discontinued due to overwhelming superiority of OMB combined with microwave heated OIT over CM avoidance.

Citing Articles

GALEN ANACARE consensus statement: Potential of omalizumab in food allergy management.

Zuberbier T, Muraro A, Nurmatov U, Arasi S, Stevanovic K, Anagnostou A Clin Transl Allergy. 2024; 14(11):e70002.

PMID: 39506193 PMC: 11540805. DOI: 10.1002/clt2.70002.

Efficacy and safety of oral immunotherapy for peanut, cow's milk, and hen's egg allergy: A systematic review of randomized controlled trials.

Lodge C, Waidyatillake N, Peters R, Netting M, Dai X, Burgess J Clin Transl Allergy. 2023; 13(7):e12268.

PMID: 37488726 PMC: 10314278. DOI: 10.1002/clt2.12268.

Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy.

Wang J, Wood R, Raymond S, Suarez-Farinas M, Yang N, Sicherer S J Allergy Clin Immunol Pract. 2023; 11(7):2208-2216.e1.

PMID: 37087097 PMC: 10330343. DOI: 10.1016/j.jaip.2023.03.051.

Oral Immunotherapy in Food Allergy: Where Are We Now?.

Gokmirza Ozdemir P, Sato S, Yanagida N, Ebisawa M Allergy Asthma Immunol Res. 2023; 15(2):125-144.

PMID: 37021501 PMC: 10079524. DOI: 10.4168/aair.2023.15.2.125.

Current Practice in Pediatric Cow's Milk Protein Allergy-Immunological Features and Beyond.

Emmert V, Lendvai-Emmert D, Eklics K, Premusz V, Toth G Int J Mol Sci. 2023; 24(5).

PMID: 36902457 PMC: 10003246. DOI: 10.3390/ijms24055025.

References

Martorell A, de la Hoz B, Ibanez M, Bone J, Terrados M, Michavila A . Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy. 2011; 41(9):1297-304. DOI: 10.1111/j.1365-2222.2011.03749.x. View

Takahashi M, Taniuchi S, Soejima K, Hatano Y, Yamanouchi S, Kaneko K . Two-weeks-sustained unresponsiveness by oral immunotherapy using microwave heated cow's milk for children with cow's milk allergy. Allergy Asthma Clin Immunol. 2016; 12(1):44. PMC: 5002153. DOI: 10.1186/s13223-016-0150-0. View

Spergel J . Natural history of cow's milk allergy. J Allergy Clin Immunol. 2013; 131(3):813-4. DOI: 10.1016/j.jaci.2013.01.027. View

Santos A, Dias A, Pinheiro J . Predictive factors for the persistence of cow's milk allergy. Pediatr Allergy Immunol. 2010; 21(8):1127-34. DOI: 10.1111/j.1399-3038.2010.01040.x. View

Suzuki K, Hiyoshi M, Tada H, Bando M, Ichioka T, Kamemura N . Allergen diagnosis microarray with high-density immobilization capacity using diamond-like carbon-coated chips for profiling allergen-specific IgE and other immunoglobulins. Anal Chim Acta. 2011; 706(2):321-7. DOI: 10.1016/j.aca.2011.08.034. View

Skripak J, Nash S, Rowley H, Brereton N, Oh S, Hamilton R . A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol. 2008; 122(6):1154-60. PMC: 3764488. DOI: 10.1016/j.jaci.2008.09.030. View

Pajno G, Caminiti L, Ruggeri P, De Luca R, Vita D, La Rosa M . Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol. 2010; 105(5):376-81. DOI: 10.1016/j.anai.2010.03.015. View

Narisety S, Skripak J, Steele P, Hamilton R, Matsui E, Burks A . Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol. 2009; 124(3):610-2. PMC: 2739248. DOI: 10.1016/j.jaci.2009.06.025. View

Sampson H . Anaphylaxis and emergency treatment. Pediatrics. 2003; 111(6 Pt 3):1601-8. View

10.

Xiong H, Dolpady J, Wabl M, Curotto de Lafaille M, Lafaille J . Sequential class switching is required for the generation of high affinity IgE antibodies. J Exp Med. 2012; 209(2):353-64. PMC: 3280879. DOI: 10.1084/jem.20111941. View

11.

Karlsson M, Rugtveit J, Brandtzaeg P . Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med. 2004; 199(12):1679-88. PMC: 2212808. DOI: 10.1084/jem.20032121. View

12.

Collins A, Jackson K . A Temporal Model of Human IgE and IgG Antibody Function. Front Immunol. 2013; 4:235. PMC: 3738878. DOI: 10.3389/fimmu.2013.00235. View

13.

Nadeau K, Schneider L, Hoyte L, Borras I, Umetsu D . Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol. 2011; 127(6):1622-4. PMC: 3396422. DOI: 10.1016/j.jaci.2011.04.009. View

14.

Patriarca G, Buonomo A, Roncallo C, Del Ninno M, Pollastrini E, Milani A . Oral desensitisation in cow milk allergy: immunological findings. Int J Immunopathol Pharmacol. 2003; 15(1):53-58. DOI: 10.1177/039463200201500107. View

15.

Patriarca G, Schiavino D, Nucera E, Schinco G, Milani A, Gasbarrini G . Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology. 1998; 45(19):52-8. View

16.

Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J . Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005; 60(3):309-16. DOI: 10.1111/j.1398-9995.2004.00772.x. View

17.

Skripak J, Matsui E, Mudd K, Wood R . The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol. 2007; 120(5):1172-7. DOI: 10.1016/j.jaci.2007.08.023. View

18.

Yeung J, Kloda L, McDevitt J, Ben-Shoshan M, Alizadehfar R . Oral immunotherapy for milk allergy. Cochrane Database Syst Rev. 2012; 11:CD009542. PMC: 7390504. DOI: 10.1002/14651858.CD009542.pub2. View

19.

Wood R, Kim J, Lindblad R, Nadeau K, Henning A, Dawson P . A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy. J Allergy Clin Immunol. 2015; 137(4):1103-1110.e11. PMC: 5395304. DOI: 10.1016/j.jaci.2015.10.005. View

20.

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M . Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001; 108(2):E36. DOI: 10.1542/peds.108.2.e36. View